POWER2DM brings together a highly experienced group of organizations consisting of individual researchers. The expertise of the partners covers a wide and complementary range of subjects, including disease research, diabetes, e-learning technologies, eHealth applications, communication, dissemination and project management. The partners and the team members have been selected carefully based on their experience and added value to the consortium, with the aim of optimizing the output of the project.


  • Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek, TNO
    • Zeist & Leiden, The Netherlands
  • Institute Of Diabetes “Gerhardt Katsch”
    • Karlsburg E.V., Germany
  • SRDC Yazilim Arastirma Ve Gelistirme Ve Danismanlik Ticaret Limited Sirketi
    • Turkey
  • Leids Universitair Medisch Centrum, LUMC
    • Leiden, The Netherlands
  • Servicio Andaluz de Salud or Andalusian Health Service (SAS) & Reina Sofia University Hospital (RSUH)
    • Spain
  • Salzburg Research Forschungsgesellschaft M.B.H.
    • Salzburg, Austria
  • iHealthlabs Europe
    • France
  • Prime Data B.V.
    • The Netherlands




Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek, TNO – Netherlands

TNO (Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO) is one of the major internationally oriented contract research and technology organisations in Europe. With a staff of approximately 3500 and an annual turnover of 580 million Euros, TNO is carrying out research in order to achieve impact on the following seven themes: Healthy Living, Industrial Innovation, Transport and Mobility, Energy, Built Environment, Information Society, and Defence, Safety and Security.
The department of Risk Analysis for Products in Development (RAPID) investigates human health risks of chemical substances, food ingredients/products, drugs and nanoparticles. Traditionally, research at RAPID takes place within (inter)national legislative frameworks but increasingly they are focusing on earlier process phases, such as the development of new ingredients and products (eg nanomaterials, drugs, new protein sources in food). The knowledge position of RAPID comprises combined in-depth knowledge of the field of risk analysis and statistics with practical experience of innovative experimental research (toxicology, chemical analysis, sensor technology, human exposure), and developing integrated strategies enabling maximal prediction of the health risks for humans and minimizing the need for animal testing. In order to reduce costs and time, computational modelling approaches increasingly lay at the basis for examining health risks posed to humans. With an increasing role for high-end statistics, they develop new methodology allowing for early indication of risks.
The department of Child health (LS) consists of about 50 professionals who have specific expertise in monitoring of health and health behavior, behavior change, planned development of evidence-based interventions with a focus on prevention and care, implementation strategies, and evaluation research regarding the (cost-)effectiveness of interventions, also with regard to sustainable participation and implementation fidelity. Within the department there is considerable expertise on online, tailored interventions and mobile health applications.

Institute Of Diabetes “Gerhardt Katsch” Karlsburg E.V. – Germany

For over 75 years the Institute of Diabetes “Gerhardt Katsch” Karlsburg (IDK), Germany, has been internationally recognized for diabetes research and treatment. It has a high concentration of renowned scientists and was chosen as the Collaborating Center of the WHO in 1986. The main goals of the Institute are to promote clinical research from bench to bedside to contribute efficiently to high quality and cost-effective treatment of diabetes. Its worldwide reputation was established over decades by consistent, outstanding research in the field of diabetes.
During the last decades the institution explored new inroads for improvement of diabetes control. For example, the development of the glucose sensor was rooted in research undertaken at the Institute in Karlsburg in the 1980s. Moreover, the worldwide unique Karlsburg Diabetes Management System (KADIS®) was developed over the past three decades by IDK researchers involved in the mathematical modeling of physiological glucose-insulin interactions. Important steps were the verification of the Karlsburg model of the insulin/glucose metabolism, which provides the basis for the development of knowledge-based, personalized decision support systems (PDS) which were first verified for the type 1 and later on for type 2 diabetes. Several evaluation studies have convincingly demonstrated the benefit of PDS for diabetes health care by supporting general practitioners in their daily efforts to optimize diabetes control of their patients. Currently, the Institute of Diabetes is focusing its research work on the development of innovative technology including telemedicine to support efficiently diabetes health care. The primary goals of these research activities are to improve the quality of life of patients with diabetes as well as prevention and/or delay of late complications. Since 2006 the IDK together with the Diabetes Service Center Karlsburg runs a PDS-supported diabetes health care program in Germany aimed to translate PDS from the research level to routine diabetes care.


SRDC Yazilim Arastirma Ve Gelistirme Ve Danismanlik Ticaret Limited Sirketi – Turkey

SRDC Ltd. was founded by a professional team of engineers directed by Prof. Asuman Dogac in Middle East Technical University (METU) Technopolis in 2007. SRDC is a spin-off company of the METU Software Research and Development Center, which was founded in 1991 with the support of The Scientific and Technological Research Council of Turkey (TUBITAK) and METU Faculty of Engineering. A majority of the team hold PhD and MSc degrees in Computer Engineering at METU, and the remaining are progressing.
SRDC enjoys strong backing from the university for transferring the R&D efforts to the industry and public administrations. We perform R&D activities both for developing brand new products and services and for innovative improvement of existing products and services. We have extensive expertise in large-scale software development, interoperability standards and enabling technologies, semantic web technologies, interoperability solutions for e-health, e-government and e-business domains, data analytics, conformance and interoperability testing, and mobile application development.

Leids Universitair Medisch Centrum, LUMC – Netherlands

The Leiden University Medical Center (LUMC) is one of eight Dutch university medical hospitals and is situated in the west of the Netherlands. Currently employing approximately 7,000 staff members, the LUMC has a long tradition of pioneering medical and bio-medical research and is recognized as one of the top international leaders in this field. The LUMC research strategy is strongly focused on cross-disciplinary and international orientation. The LUMC aims at identifying the causes of disease, improving diagnosis, prevention, and ultimately developing effective treatments.
The LUMC acts as a knowledge center for topics in the field of public health with an impact on society. It has a directive function in the region and acts as a center for continuing education and further training for medical professionals. The collaboration between the LUMC, Leiden University and the Leiden Bio Science Park creates unique possibilities for medical innovation in Leiden and the surrounding area. The LUMC has extensive experience in leading and participating in large research programs, including those funded by FP6, FP7 and H2020. In the 7th Framework Program, the LUMC obtained funding for 126 projects with a total value of 95.8 M€. The LUMC coordinated 33 of these FP7 grants.
The current project fits in the LUMC profile area of Innovation in Health Strategy and Quality of Care, which is aimed at providing a scientific basis for changes in health care. The embedding of the strong multidisciplinary research department of Medical Decision Making in the Leiden Quality of Care Institute, including physicians, health psychologists, health economists, implementation scientists and epidemiologists, provides a unique situation for quality of care research. In this position research has a strong clinical profile and is performed in collaboration with multiple clinical departments across all divisions of the LUMC, including the Departments of Endocrinology, Public Health, and Primary Care.
Within the Department of Endocrinology, the Diabetes Center Leiden will be the central point of research for POWER2DM within the LUMC. The Diabetes Center Leiden specializes in multi-disciplinary, patient-centered treatment of all forms of diabetes and has a strong focus on research aimed at improving the treatment of diabetes and its complications, as well as figuring out the causes that lead to diabetes. Through innovative scientific research, the Diabetes Center Leiden is working on innovative therapies and is well situated to be a partner in POWER2DM.

Servicio Andaluz De Salud – Spain

Servicio Andaluz de Salud or Andalusian Health Service (SAS) is an autonomous body attached to the Ministry of Health of the Government of Andalusia in the South of Spain. Its mission is to provide public quality health care to the citizens, seeking efficiency and optimum use of resources. SAS has a network of integrated care services and it is organized to ensure the accessibility of the population. There are 1,491 primary care centres, 29 hospitals and 84.706 employees. The specific task of this project will be carried out at one of its hospitals: Reina Sofia University Hospital (RSUH).
Description of the organisation: RSUH is a centre for specialized medical care, teaching and research in health sciences, located in the city of Cordoba. Its service portfolio covers all specialized clinical areas. RSUH will perform the tasks through its Research Institute IMIBIC (Maimonides Biomedical Research Institute of Cordoba), jointly owned by RSUH and the University of Cordoba. IMIBIC is accredited within the framework of health centers of excellence recognised by the National Institute of Health Carlos III.
The group participating in this project will be the Lipids and Atherosclerosis Unit, Department of Internal Medicine of RSUH, which is as well a research group ascribed to IMIBIC. The group consists of about 21 researchers and is dedicated to the research excellence will advance knowledge related to diet, biomedicine, physical activity and bioscience to facilitate translation into public health. For more than 20 years, the group has studied the gene-diet interaction and its relation with the cardiovascular disease; the insulin resistance and the metabolic syndrome as the main risk factor for type 2 diabetes and Cardiovascular diseases.

Salzburg Research Forschungsgesellschaft M.B.H. – Austria

Salzburg Research Forschungsgesellschaft is the non-profit research and technology organisation (RTO) of the State of Salzburg and is specialised in applied research and development in the field of information and communication technologies (ICT) and New Media. Salzburg Research has more than 15 years’ experience in national and international projects and covers a vast area of scientific expertise including knowledge based modelling, social media, content management and semantic technologies. We presently employ 60 researchers across our application areas of eHealth, eEnergy, eTourism and Industrial Internet.
SRFG’s eHealth expertise covers ICT-based Patient Empowerment concepts and technologies, knowledge modelling of explicit and implicit medical knowledge, knowledge-based system, semantic technologies, social media for medical applications, semantic interoperability and medical terminologies.

iHealthlabs Europe – France

iHealth is a worldwide leader in connected health. Historically a manufacturer of medical devices, iHealth connected all of its clinically validated medical devices to smartphones in 2008, thus heralding a new era of medical diagnostics where people could not only measure their vital signs, but also track, manage and share them with medical professionals.
iHealthLabs Europe, established in Paris in 2013, is creating new value for its users and customers by creating innovative solutions for the management of chronic diseases such as diabetes and hypertension.

Prime Data B.V. – Netherlands

It is the mission of Prime Data to make our Real Time Analytics & Intelligence services faster accessible and thereby turning our clients’ challenges into a competitive advantage.
Prime Data mainly focuses on the back-end of cloud based intelligent solutions. In this respect Prime Data processes data with intelligent software, provides customers with (historical) insight, real-time insight, predicted insights and smart information-based solutions. Central goal is to enhance the capabilities of service providers to effectively act on current and predicted information. Thereby turning data into actionable knowledge. Core asset of Prime Data is its enterprise cloud platform. Currently Prime Data is providing real-time intelligent business services in several industries (e.g. mobility, logistics, smart health and smart cities and -industries) together with the Dutch road authority Rijkswaterstaat, media company RTL, WaterNet, and the LUMC and TNO.
Current business services are:

  • data enrichment as a service
  • knowledge discovery as a service
  • anomaly detection as a service
  • PatientCoach as a service
  • disease management advice as a service
  • process optimization as a service
  • route optimization as a service

For these services Prime Data constructed its managed enterprise cloud platform that, besides the business services, also comprises of management components such as billing, user management, load management, back-up and storage management.